Literature DB >> 28724492

Evaluation of Pain Assessment Techniques and Analgesia Efficacy in a Female Guinea Pig (Cavia porcellus) Model of Surgical Pain.

Vanessa L Oliver1, Stephanie Athavale1, Katherine E Simon1, Lon V Kendall2, Jean A Nemzek1, Jennifer L Lofgren3.   

Abstract

Guinea pigs (Cavia porcellus) are a frequently used species in research, often involving potentially painful procedures. Therefore, evidence-based recommendations regarding analgesia are critically needed to optimize their wellbeing. Our laboratory examined the efficacy of carprofen and extended-release (ER) buprenorphine, alone and as a multimodal combination, for relieving postsurgical pain in guinea pigs. Animals were assessed by using evoked (mechanical hypersensitivity), nonevoked (video ethogram, cageside ethogram, time-to-consumption test), and clinical (weight loss) measurements for 96 h during baseline, anesthesia-analgesia, and hysterectomy conditions. In addition, ER buprenorphine was evaluated pharmacologically. Guinea pigs treated with a single analgesic showed increased mechanical sensitivity for at least 96 h and indices of pain according to the video ethogram for as long as 8 h, compared with levels recorded during anesthesia-analgesia. In contrast, animals given both analgesics demonstrated increased mechanical sensitivity and behavioral evidence of pain for only 2 h after surgery compared with anesthesia-analgesia. The cageside ethogram and time-to-consumption tests failed to identify differences between conditions or treatment groups, highlighting the difficulty of identifying pain in guinea pigs without remote observation. Guinea pigs treated with multimodal analgesia or ER buprenorphine lost at least 10% of their baseline weights, whereas weight loss in carprofen animals was significantly lower (3%). Plasma levels for ER buprenorphine exceeded 0.9 ng/mL from 8 to 96 h after injection. Of the 3 analgesia regimens evaluated, multimodal analgesia provided the most effective pain control in guinea pigs. However the weight loss in the ER buprenorphine-treated animals may need to be considered during analgesia selection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28724492      PMCID: PMC5517332     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  53 in total

1.  Topical anaesthesia alleviates short-term pain of castration and tail docking in lambs.

Authors:  S Lomax; H Dickson; M Sheil; P A Windsor
Journal:  Aust Vet J       Date:  2010-03       Impact factor: 1.281

Review 2.  What should we be measuring in behavioral studies of chronic pain in animals?

Authors:  Jeffrey S Mogil; Sara E Crager
Journal:  Pain       Date:  2004-11       Impact factor: 6.961

3.  Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus).

Authors:  Helen H Chum; Katechan Jampachairsri; Gabriel P McKeon; David C Yeomans; Cholawat Pacharinsak; Stephen A Felt
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

4.  Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice.

Authors:  Mari A Griffioen; Valerie H Dernetz; Gee Su Yang; Kathleen A Griffith; Susan G Dorsey; Cynthia L Renn
Journal:  Nurs Res       Date:  2015 Mar-Apr       Impact factor: 2.381

5.  Effects of infiltration of the incision site with bupivacaine on postoperative pain and incisional healing in dogs undergoing ovariohysterectomy.

Authors:  Courtney L Fitzpatrick; Heather L Weir; Eric Monnet
Journal:  J Am Vet Med Assoc       Date:  2010-08-15       Impact factor: 1.936

6.  Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride.

Authors:  Brian J Smith; Daniel J Wegenast; Ryan J Hansen; Ann M Hess; Lon V Kendall
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-11       Impact factor: 1.232

7.  Evaluation of a short duration behaviour-based post-operative pain scoring system in rats.

Authors:  John V Roughan; Paul A Flecknell
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

8.  Age-dependent responses to thermal hyperalgesia and mechanical allodynia in a rat model of acute postoperative pain.

Authors:  Douglas G Ririe; Teri L Vernon; Joseph R Tobin; James C Eisenach
Journal:  Anesthesiology       Date:  2003-08       Impact factor: 7.892

9.  Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.

Authors:  Monica Escher; Youssef Daali; Jocelyne Chabert; Gérard Hopfgartner; Pierre Dayer; Jules Desmeules
Journal:  Clin Ther       Date:  2007-08       Impact factor: 3.393

10.  Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain.

Authors:  Thomas J Martin; Nancy L Buechler; William Kahn; James C Crews; James C Eisenach
Journal:  Anesthesiology       Date:  2004-07       Impact factor: 7.892

View more
  4 in total

1.  Enrichment Preferences of Singly Housed Zebrafish (Danio rerio).

Authors:  Lauren D Krueger; Sarah E Thurston; Joshua Kirk; Fairouz Elsaeidi; Zachary T Freeman; Daniel Goldman; Jennifer L Lofgren; Jill M Keller
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-05       Impact factor: 1.232

2.  Effects of Buprenorphine Treatment on Influenza Pathogenesis in the Ferret (Mustela putorius furo).

Authors:  Victoria J Mrotz; Kaitlyn M Nestor; Taronna R Maines; Nathaniel Powell; Jessica A Belser
Journal:  Comp Med       Date:  2022-02-01       Impact factor: 1.565

3.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

Review 4.  A Review of Pain Assessment Methods in Laboratory Rodents.

Authors:  Patricia V Turner; Daniel Sj Pang; Jennifer Ls Lofgren
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.